REFERENCES
- Iwai T, Baba J, Murata S, Mitsudo K, Maegawa J, Nagahama K, Tohnai I. Warthin tumor arising from the minor salivary gland. J Craniofac Surg 2012;23(5):e374–e376.
- Cardoso SV, do Nascimento Souza KC, de Faria PR, Lima RA, Nascimento MF, Eisenberg AL, Dias FL, Loyola AM. Warthin's tumor at the Brazilian National Cancer Institute: additional evidence of homogeneous sex prevalence and association with other neoplasms. ORL J Otohrinolaryngol Relat Spec 2008;70(6):339–343.
- Freedman LS, Oberman B, Sadetzki S. Using time-dependent covariate analysis to elucidate the relation of smoking history to Warthin's tumor risk. Am J Epidemiol 2009;170(9):1178–1185.
- Laco J, Celakovsky P, Kalfert D, Hornychova H, Rybnikar T, Ryska A. Tumor-to-tumor metastasis: Warthin tumor as a recipient of lung carcinoma and of renal carcinoma - Report of two cases. Path Res Pract 2010;206(7):458–462.
- Arora R, Singh H, Vashistha R, Gupta RK, Jain S, Kapoor P, Aggarwal R. Indian J Chest Dis Allied Sci 1997;39(3):183–188.
- Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 1999;120(6):834–840.
- Kotwall CA. Smoking as an etiologic factor in the development of Warthin's tumor of the parotid gland. Am J Surg 1992;164(6):646–647.
- Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
- Centers for Disease Control and Prevention (CDC). State-specific trends in lung cancer incidence and smoking–United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011;60(36):1243–1247.
- Thomas R, Sharma N, Burke C, Maxwell D, Howlett DC. Parotid incidentaloma detected during thoracic PET imaging: how should these lesions be managed? Br J Hosp Med 2010;71(5):292–293.
- Holder WD Jr, White RL Jr, Zuger JH, Easton EJ Jr, Greene FL. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998;227(5):764–769.
- Jeong WJ, Park SJ, Cha W, Sung MW, Kim KH, Ahn SH. Fine needle aspiration of parotid tumors: diagnostic utility from a clinical perspective. J Oral Maxillofac Surg 2013;71(7):1278–1282.
- Seethala RR, LiVolsi VA, Baloch ZW. Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland. Head Neck 2005;27(3):217–223.
- Jo HJ, Ahn HJ, Jung S, Yoon HK. Diagnostic difficulties in fine needle aspiration of benign salivary glandular lesions. Korean J Pathol 2012;46(6):569–575.
- Lewis PD, Fradley SR, Griffiths AP, Baxter PW, Parry JM. Mitochondrial DNA mutations in the parotid gland of cigarette smokers and non-smokers. Mutat Res 2002;518(1):47–54.
- Clauditz TS, Gontarewicz A, Lebok P, Tsourlakis MC, Grob TJ, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W. Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target. Oral Oncol 2012;48(10):991–996.
- National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395–409.